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Abstract
There exist four fundamentally different classes of membrane-bound transport proteins: ion channels; transpor-
ters; aquaporins; and ATP-powered pumps. ATP-binding cassette (ABC) transporters are an example of ATP-
dependent pumps. ABC transporters are ubiquitous membrane-bound proteins, present in all prokaryotes,
as well as plants, fungi, yeast and animals. These pumps can move substrates in (inﬂux) or out (efﬂux) of cells.
In mammals, ABC transporters are expressed predominantly in the liver, intestine, blood–brain barrier,
blood–testis barrier, placenta and kidney. ABC proteins transport a number of endogenous substrates, including
inorganic anions, metal ions, peptides, amino acids, sugars and a large number of hydrophobic compounds and
metabolites across the plasma membrane, and also across intracellular membranes. The human genome contains
49 ABC genes, arranged in eight subfamilies and named via divergent evolution. That ABC genes are important is
underscored by the fact that mutations in at least 11 of these genes are already known to cause severe inherited
diseases (eg cystic ﬁbrosis and X-linked adrenoleukodystrophy [X-ALD]). ABC transporters also participate in
the movement of most drugs and their metabolites across cell surface and cellular organelle membranes; thus,
defects in these genes can be important in terms of cancer therapy, pharmacokinetics and innumerable pharma-
cogenetic disorders.
Keywords: human genome, human ATP-binding cassette (ABC) transporter gene family, genetic polymorphism, evolution,
drug transport, cancer chemotherapy
Introduction
Membrane transport proteins can be divided into
four types: ion channels; transporters; aquaporins;
and ATP-powered pumps (http://www.ncbi.nlm.
nih.gov/books/bv.fcgi?rid=mcb.ﬁggrp.4031). Genes
from all four categories are ancient — with
members present in most, if not all, prokaryotes, as
well as in virtually all cell types of all eukaryotes.
Transporters in eukaryotic cells move ions, sugars,
amino acids and other molecules across all cellular
and organelle membranes (cell surface, mitochon-
drial, endoplasmic reticulum, Golgi apparatus and
other vesicles) — with the possible exception of
nuclear membranes (which have pores). The portion
of the cell exposed to the lumen is called the apical
surface; the rest of the cell (ie sides and base) makes
up the basolateral surface. Movement of ions or
other molecules into the cell is called inﬂux; move-
ment of ions or other molecules out of the cell is
termed efﬂux.
Membrane transport proteins can be either
passive or active. Passive transporters (also called uni-
porters or facilitative transporters) transport sub-
strates down a concentration gradient. By contrast,
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movement of one type of ion or molecule against its
concentration gradient, to the movement of another
ion or molecule down its concentration gradient.
Like ATP pumps, cotransporters mediate coupled
reactions in which an energetically unfavourable
reaction is coupled to an energetically favourable
reaction. When the transported molecule and
cotransported ion move in the same direction across
a membrane, the transporter is called a symporter;
when they move in opposite directions, the trans-
porter is called an antiporter (or exchanger). If the
intracellular net charge following transport becomes
more negative, the process is termed electronegative;
if the intracellular net charge becomes more
positive, the process is called electropositive; if
the resulting intracellular net charge remains
unchanged, the process is termed electroneutral.
Ion channels are pore-forming membrane pro-
teins that help to establish and maintain small-
voltage gradients across plasma membrane surfaces
of all living cells. As such, they regulate the cell’s
electric potential by allowing the ﬂow of ions down
their electrochemical gradient. Ion channels usually
occur in the closed state. Cationic and anionic sub-
strates are transferred down their electrochemical
gradients at extremely high efﬁciencies (as much as
10
8 sec
21). More than 400 genes are known to
encode ion channel subunits.
1
Transporters facilitate the movement of a speciﬁc
substrate — either with or against its concentration
gradient — and the conformational change in the
transporter protein is important in this transfer
process. Transporters move molecules at only about
10
2–10
4 sec
21, a rate much slower than that associ-
ated with channel proteins. Many of these transpor-
ters belong to the solute-carrier (SLC) gene
superfamily, and include passive transporters, sym-
porters and antiporters, as well as mitochondrial
and vesicular transporters. The SLC superfamily
comprises 55 gene families, having at least 362
putatively functional protein-coding genes.
2
Aquaporins are a unique class of transporter.
These proteins are bi-directional membrane channels
which transport water, but they are not ion channels
because the H2O is transported as an uncharged
molecule and not as an ion. The driving force for
aquaporins is the presence of osmotic gradients
across membranes.
3 There are 13 putatively func-
tional AQP genes in the human genome (http://
www.genenames.org/).
ATP-powered pumps include the ATP-binding
cassette (ABC) pumps. These pumps use energy
released by ATP hydrolysis to move substrates across
membranes in or out of cells or into cellular vesicles,
against their electrochemical gradient. ABC pumps
constitute a large, diverse and ubiquitous superfamily.
Most ABC genes encode membrane-bound proteins
that participate directly in the transport of a wide
range of molecules across membranes.
4 ABC trans-
porters can broadly be categorised as importers or
exporters, depending on the direction of transport
relative to the cytoplasm.
5 Plants carry a particularly
large complement of ABC proteins; these pumps are
associated with the need to establish steep concen-
tration gradients of solutes across cellular membranes,
as well as metabolic versatility. Plant ABC pumps are
not only involved in the transport of hormones,
lipids, secondary metabolites, metals and xenobiotics,
4
but also contribute to osmolality and ion channel and
phytoalexin functions (plant–pathogen interactions).
Even the evolution of seed size in the tomato has
been associated with an ABC transporter gene.
6
Details of the ABC proteins
By deﬁnition, ABC proteins possess an ATP binding
cassette, also known as the ‘nucleotide-binding
domain’ (NBD). The NBD contains several highly
conserved motifs, including the Walker A and Walker
B sequences, the ABC signature motif, the H loop
and the Q loop. ABC transporters also contain trans-
membrane domains (TMDs), each of which com-
prises several hydrophobic a-helices. The ABC
transporter core unit consists of four domains, two
NBDs and two TMDs. The two NBDs together
bind and hydrolyse ATP (thereby providing the
driving force for transport), while the TMDs partici-
pate in substrate recognition and translocation across
the lipid membrane.
4 Some ABC genes encode pro-
teins that are ‘half-transporters’ (meaning that two
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whereas others are ‘full-transporters’.
The human ABC gene family
The human genome carries 49 ABC genes,
arranged in seven subfamilies, designated A to G
(Figure 1 and Table 1). This diverse transporter
family has members that play pivotal roles in many
cellular processes. For example, ABC transporters
are responsible for the multidrug resistance of cancer
cells.
7 ABC proteins also transport a number of sub-
strates, including metal ions, peptides, amino acids,
sugars and a large number of hydrophobic com-
pounds and metabolites across the plasma membrane,
and also intracellular membranes. The function of
each ABC gene product, when known, is listed in
the far right column of Table 2. At the present time,
21 ABC pseudogenes have been identiﬁed
8 and
localised to chromosomal regions (Table 3).
Mutations in at least 11 ABC genes to date are
clearly associated with inherited diseases:
10 Tangier
disease T1 (ABCA1); Stargardt disease, retinitis
pigmentosa and age-related macular degeneration
(ABCA4); progressive familial intrahepatic cholestasis
(ABCB11); Dubin–Johnson syndrome (ABCC2);
pseudoxanthoma elasticum (ABCC6); cystic ﬁbrosis
(ABCC7); X-linked adrenoleukodystrophy (ALD)
(ABCD1 and ABCD2); some forms of Zellweger
syndrome (ABCD3 and ABCD2) and sitosterolaemia
(a rare lipid metabolic disorder inherited as an auto-
somal recessive trait) (ABDG5 and ABCG8). An
additional eight ABC genes have been implicated in,
or are candidates for, other metabolic inherited dis-
eases (http://nutrigene.4t.com:80/humanabc.htm).
Clans: Comments on sequence
identity
The ABC family is a member of the
P-loop-containing nucleoside-triphosphate hydrolase
clan (CL0023). The deﬁnition of the clan in the Pfam
database is: ‘A collection of evolutionarily-related
Pfam entries. This relationship may be deﬁned by
similarity of protein sequence, tertiary structure or
proﬁle, as deﬁned by the Hidden Markov model’.
11,12
At the moment, clan CL0023 contains 55 protein
families, including the ABC family.
Subfamily A of the ABC family
(ABCA)
Subfamily A contains 12 genes, most of which
appear to be involved in lipid trafﬁcking in many
diverse organs and cell types. Among the largest of
the ABC transporters, some of the ABCA proteins
weigh in at more than 2,100 amino acids in
length.
10 In fact, the predicted ABCA13 protein
contains 5,058 residues, making it the largest ABC
protein known. Mutations in speciﬁc ABCA genes
lead to genetic disorders,
13 such as Tangier disease
T1, familial high-density lipoprotein (HDL)
deﬁciency, Stargardt disease-1, age-related macular
degeneration and retinitis pigmentosa (Table 2).
Subfamily B of the ABC family
(ABCB)
This subfamily of 11 genes is unique to mammals;
there are four full-transporters and seven half-
transporters. Several of the B family members are
known to confer multidrug resistance in cancer
cells; hence, subfamily B has also been called the
‘MDR family of ABC transporters’.
10 Mutations in
ABCB genes have been implicated in ankylosing
spondylitis, diabetes type 2, coeliac disease, lethal
neonatal syndrome, X-linked sideroblastic anaemia
with ataxia, and several cholestatic liver diseases
of infancy (Table 2). Many of these genotype–
phenotype association studies suggesting the invol-
vement of ABCB genes, however, are likely to
represent false-positive, inconclusive or under-
powered studies, and need further replication in
other large cohorts before they can be regarded as
‘informative’ and conclusive.
14
Recent genome-wide searches for positive selec-
tion in the human genome have suggested the
possibility that the metabolism and transport of
foreign chemicals (foodstuffs, plant metabolites and
drugs) might have undergone natural selection.
15–17
In this regard, the 230-kilobase (kb) cluster of four
cytochrome P450 3A (CYP3A) functional genes
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# HENRY STEWART PUBLICATIONS 1479–7364. HUMAN GENOMICS. VOL 3. NO 3. 281–290 APRIL 2009 283Figure 1. Clustering dendrogram of the human ATP-binding cassette (ABC) transporter genes. The root ‘ABC’ is omitted from the
ﬁgure to simplify it. Thus, the correct gene name for ‘B1’ is ABCB1, for ‘B4’ is ABCB4, and so forth.
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only 119 kb distant from the ABCB1 gene (the
transcript of which spans 210 kb). Moreover, the
CYP3A enzymes and ABCB1 transporter appear to
have very similar substrate proﬁles, and both are
regulated by the pregnane X receptor (PXR) in the
liver, intestine, lung and kidney.
18 In addition,
positive selection has recently been noted in the
ligand-binding domain of PXR,
19 lending further
credence to the possible co-evolution of these two
nearby loci, in response to dietary pressures. Future
investigators should look carefully for similar
patterns of possible co-evolution by other drug-
metabolising genes and drug-transporter genes.
Subfamily C of the ABC family
(ABCC)
Subfamily C includes the cystic ﬁbrosis gene
(CFTR, also called ABCC7) plus 12 other genes
that encode transporters associated with multidrug
resistance. The diverse activities of ABCC transpor-
ters include ion-channel and toxin excretion
activity and reception on the cell surface; toxin
excretion involves various fungal and bacterial
toxins.
10 Mutations in one or more of the ABCC
genes have been implicated in multidrug resistance,
Dubin–Johnson syndrome, congenital bilateral
aplasia of the vas deferens, diabetes type 2 and par-
oxysmal kinesigenic choreoathetosis — as well as
autosomal recessive diseases such as cystic ﬁbrosis,
pseudoxanthoma elasticum and hyperinsulinaemic
hypoglycaemia of infancy (Table 2).
The CFTR encodes a unique ABC transporter
protein. Recent data suggest that CFTR channel
activity evolved by converting the conformational
changes associated with ATP binding and hydrolysis
(found in ‘true’ ABC pumps) into an open per-
meation pathway, by means of intra-protein inter-
actions that stabilise the open state.
20 The ‘selective
pressure’ in the environment that might have
encouraged this unique CFTR protein to evolve to
exhibit this characteristic has been suggested to be
severe infection — that is, cholera epidemics.
21
Subfamily D of the ABC family
(ABCD)
Also known as the peroxisomal or ALD transporters,
this subfamily contains four genes that encode half-
transporters; these subunits form homodimers or
heterodimers to make a functional unit. These four
human half-transporter genes code for at least 49 dis-
tinct proteins by means of 102 alternatively spliced
transcripts.
10 Mutations in ADBD genes are known
to cause ALD and Zellweger syndrome (Table 2).
Subfamily E of the ABC family
(ABCE)
ABCE1 is the single member in this family which
is an organic anion-binding protein (its trivial name
is OABP), sometimes confused with the 11 SLCO
genes that encode solute-carrier organic anion
transporters.
2 ABCE1 has an ATP-binding domain
but lacks the transmembrane domain, making it
unlikely that this protein functions as a transporter.
Because of 15 alternatively spliced transcripts, the
ABCE1 gene encodes ﬁve distinct proteins.
10
ABCE1 has been found to block the activity of
ribonuclease L. Activation of ribonuclease L leads
to inhibition of protein synthesis in a pivotal
pathway involving viral interferon action; hence,
ABCE1 functions to promote interferon activity.
Table 1. Human ABC gene subfamilies
Subfamily
name
Aliases Number
of genes
Number of
pseudogenes
ABCA ABC1 12 5
ABCB MDR 11 4
ABCC MRP 13 2
ABCD ALD 4 4
ABCE OABP 1 2
ABCF GGN20 3 2
ABCG White 5 2
Total 49 21
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Gene Chromosome
location
Exons AA Accession
number
Function
ABCA1 9q31.1 36 2261 NM005502 Cholesterol efflux onto HDL
ABCA2 9q34 27 2436 NM001606 Drug resistance
ABCA3 16p13.3 26 1704 NM001089 Multidrug resistance
ABCA4 1p22 38 2273 NM000350 N-retinylidene-phosphatidylethanolamine
(PE) efflux
ABCA5 17q24.3 31 1642 NM018672 Urinary diagnostic marker for prostatic
intraepithelial neoplasia (PIN)
ABCA6 17q24.3 35 1617 NM080284 Multidrug resistance
ABCA7 19p13.3 31 2146 NM019112 Cholesterol efflux
ABCA8 17q24 31 1581 NM007168 Transports certain lipophilic drugs
ABCA9 17q24.2 31 1624 NM080283 Might play a role in monocyte
differentiation and macrophage lipid
homeostasis
ABCA10 17q24 27 1543 NM080282 Cholesterol-responsive gene
ABCA12 2q34 37 2595 NM173076 Has implications for prenatal diagnosis
ABCA13 7p12.3 36 5058 NM152701 Inherited disorder affecting the pancreas
ABCB1 7q21.1 20 1280 NM000927 Multidrug resistance
ABCB2 (TAP1) 6p21.3 11 808 NM000593 Peptide transport
ABCB3 (TAP2) 6p21.3 11 703 NM000544 Peptide transport
ABCB4 7q21.1 25 1279 NM000443 Phosphatidylcholine (PC) transport
ABCB5 7p15.3 17 812 NM178559 Melanogenesis
ABCB6 2q36 19 842 NM005689 Iron transport
ABCB7 Xq12-q13 14 753 NM004299 Fe/S cluster transport
ABCB8 7q36 15 718 NM007188 Intracellular peptide trafficking across
membranes
ABCB9 12q24 12 766 NM019625 Located in lysosomes
ABCB10 1q42.13 13 738 NM012089 Export of peptides derived from
proteolysis of inner-membrane proteins
ABCB11 2q24 26 1321 NM003742 Bile salt transport
ABCC1 16p13.1 31 1531 NM004996 Drug resistance
ABCC2 10q24 26 1545 NM000392 Organic anion efflux
Continued
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Gene Chromosome
location
Exons AA Accession
number
Function
ABCC3 17q22 19 1527 NM003786 Drug resistance
ABCC4 13q32 19 1325 NM005845 Nucleoside transport
ABCC5 3q27 25 1437 NM005688 Nucleoside transport
ABCC6 16p13.1 28 1503 NM001171 Expressed primarily in liver and kidney
ABCC7 (CFTR) 7q31.2 23 1480 NM000492 Chloride ion channel (same as CFTR gene
in cystic fibrosis)
ABCC8 11p15.1 30 1581 NM000352 Sulfonylurea receptor
ABCC9 12p12.1 32 1549 NM005691 Encodes the regulatory SUR2A subunit of
the cardiac K
þ(ATP) channel
ABCC10 6p21.1 19 1464 NM033450 Multidrug resistance
ABCC11 16q12.1 25 1382 NM033151 Drug resistance in breast cancer
ABCC12 16q12.1 25 1359 NM033226 Multidrug resistance
ABCC13 21q11.2 6 325 NM00387 Encodes a polypeptide of unknown
function
ABCD1 Xq28 9 745 NM000033 Very-long-chain fatty acid (VLCFA)
transport
ABCD2 12q11–q12 10 740 NM005164 Major modifier locus for clinical diversity
in X-linked ALD (X-ALD)
ABCD3 1p22–p21 16 659 NM002858 Involved in import of fatty acids and/or
fatty acyl-coenzyme As into the
peroxisome
ABCD4 14q24 19 606 NM005050 May modify the ALD phenotype
ABCE1 4q31 14 599 NM002940 Oligoadenylate-binding protein
ABCF1 6p21.33 19 845 NM001025091 Susceptibility to autoimmune pancreatitis
ABCF2 7q36 14 634 NM005692 Tumour suppression at metastatic sites and
in endocrine pathway for breast cancer/
drug resistance
ABCF3 3q27.1 21 709 NM018358 Also present in promastigotes (one of five
forms in the life cycle of trypanosomes)
ABCG1 21q22.3 13 678 NM004915 Cholesterol transport
Continued
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(ABCF)
Along with ABCE1, ABCF members also have
ATP-binding domains, but no transmembrane
domains, making transporter function unlikely. Due
to alternatively spliced products, the three ABCF
genes encode 26 distinct proteins.
10 Because the
ABCF genes appear to be upregulated by tumour
necrosis factor-a, it is believed that members of this
subfamily might play a role in inﬂammatory pro-
cesses. No diseases have been associated, so far,
with either the ABCE or ABCF genes (Table 2).
Subfamily G of the ABC family
(ABCG)
Subfamily G comprises at least ﬁve genes that
encode ‘reverse half-transporters’, meaning that
they form the second half of a heterodimer.
Mutations in ABCG genes have been implicated in
sterol accumulation disorders and atherosclerosis
(Table 2). Due to alternative splicing, at least 18
distinct subunit proteins have been identiﬁed as
products of the ﬁve ABCG genes.
10 ABCG1 is
involved in cholesterol efﬂux in macrophages and
may regulate cellular lipid homeostasis in other cell
types as well. ABCG2 functions in multidrug resist-
ance transport; steroids (cholesterol, oestradiol, pro-
gesterone and testosterone) and certain chlorophyll
metabolites, as well as organic anions, are trans-
ported by ABCG2. ABCG3 is expressed at high
levels in the thymus and spleen, suggesting a poss-
ible potential role in the transport of speciﬁc
Table 2. Continued
Gene Chromosome
location
Exons AA Accession
number
Function
ABCG2 4q22 16 655 NM004827 Toxicant efflux, drug resistance
ABCG4 11q23.3 15 646 NM022169 Found in macrophage, eye, brain and
spleen
ABCG5 2p21 11 651 NM022436 Sterol transport
ABCG8 2p21 10 673 NM022437 Sterol transport
Abbreviations: HGNC, HUGO Gene Nomenclature Committee; AA, number of amino acids; HDL, high density lipoprotein; CFTR, cysticﬁbrosis transmembrane conductance
regulator gene; ATP, adenosine triphosphate; ALD, adrenoleukodystrophy.
Table 3. Human ABC transporter pseudogenes (adapted and
modified from Piehler et al.
8)
Parental
gene
Pseudogene Chromosomal
location
Accession
number
ABCA3 ABCA17P 16p13.3 DQ266102
ABCA10 ABCA10P 4p16.3 AK024359
Abca14* ABCA14P1 16p12.2
Abca15* ABCA15P1
ABCA15P2
16p12.2
16p12.1
DR731461
ABCB4 ABCB4P 4q32.1
ABCB10 ABCB10P1
ABCB10P2
ABCB10P3
15q11.2
15q13.1
15q13.1
ABCC6 ABCC6P1
ABCC6P2
16p12.3
16p13.11
DB11925
ABCD1 ABCD1P1
ABCD1P2
ABCD1P3
ABCD1P4
2p11.1
10p11.1
16p11.2
22q11.1
AY344117
ABCE1 ABCE1P1
ABCE1P2
1q31.2
7p15.3
ABCF2 ABCF2P1
ABCF2P2
3p11.2
7q11.2
ABCG2 ABCG2P1
ABCG2P2
14q24.3
15q23
*Abca14, Abca15 and Abca16 are mouse genes, with no human orthologues.
9 The
mouse genome contains 52 Abc genes, whereas the human genome carries 49 ABC
genes.
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cytes. ABCG5 and ABCG8 both appear to limit
intestinal absorption and promote biliary excretion
of sterols; their expression is localised primarily in
the liver, colon and intestine. Mutations in either of
these two genes lead to sitosterolaemia. This is
characterised by hyperabsorption plus decreased
biliary excretion of dietary sterols, leading to
hypercholesterolaemia, tendon and tuberous
xanthomata, early-age onset of atherosclerosis, and
abnormal blood and liver function test results.
Evolution of the ABC transporter
family
Clearly, the ancestral ABC gene ﬁrst appeared in
unicellular organisms and is therefore ancient,
being now present in eubacteria, archaebacteria,
plants, fungi, yeast and all animals. The nomencla-
ture of the ABC gene family is the same as that
developed for more than 150 other gene families
and superfamilies in the human and rodent
genomes (http://www.genenames.org/). All of
these nomenclature systems followed the original
example described for the CYP genes. The CYP
genes were conveniently arranged into families and
subfamilies based on percentage amino acid
sequence identity.
22–27 Enzymes that share  40
per cent or higher identity are assigned to a par-
ticular family (designated by an Arabic numeral).
Protein sequences sharing  55 per cent or higher
identity are grouped into a particular subfamily
(designated by a letter). Enzymes that share greater
than  70 per cent amino acid identity are then
named as members within that subfamily (and
given Arabic numbers, usually in the sequence in
which they were discovered).
For example, sterol 27-hydroxylase and
25-hydroxy-vitamin D3 1a-hydroxylase are both
assigned to the CYP27 family because they share
.40 per cent sequence identity. Because their
protein sequences are ,55 per cent identical,
however, sterol 27-hydroxylase is assigned to the
CYP27 ‘A’ subfamily and 25-hydroxy-vitamin D3
1a-hydroxylase to the ‘B’ subfamily. If another
enzyme were to be discovered that shared .55 per
cent identity with sterol 27-hydroxylase, it would
be named CYP27A2. Another enzyme was discov-
ered that shared ,55 per cent but .40 per cent
identity with sterol 27-hydroxylase, as well as with
the 25-hydroxy-vitamin D3 1a-hydroxylase, and
therefore it was named CYP27C1. The develop-
ment and application of this pleasingly logical
system of nomenclature to the genes of many
animals, plants and bacteria (http://drnelson.
utmem.edu/CytochromeP450.html) has eliminated
the confusion that often has plagued the naming of
gene families and superfamilies. Subsequently, this
‘divergent evolution’ nomenclature system has been
adopted for the ABC gene family, among many
others. The human subfamilies and members
within each subfamily can be seen (Figure 1) to
have diverged over evolutionary time. The nomen-
clature for both the human ABC gene family and
the CYP gene superfamily has been approved by
the HUGO Gene Nomenclature Committee
(HGNC; http://www.genenames.org).
Conclusions
The family of ABC pumps, along with the super-
family of SLC proteins summarised in the last issue
of Human Genomics,
2 are among the most import-
ant large classes of transporters that move inorganic
ions, metals, peptides, steroids, nucleosides, sugars
and many other small molecules across the cell’s
surface membrane, as well as organelle membranes
within cells. The ABC gene family of transporters
comprises 49 and 52 genes (in eight subfamilies) in
the human and mouse genomes, respectively; the
nomenclature of these genes is based strictly on
divergent evolution. The SLC gene superfamily is
composed of 362 genes in 55 families in the
human genome; the nomenclature of those genes is
based largely on biochemical function, rather than
divergent evolution from a common ancestor.
2
The ABC transporters are critically important in
innumerable physiological functions, underscored
by the fact that defects in more than a dozen of
these genes have been associated with severe inher-
ited disorders of metabolism — cystic ﬁbrosis being
among the most prominent diseases, caused by
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ters are also of great clinical importance in the
transport of cancer chemotherapeutics, numerous
other drugs and metabolites, and many chemicals
present in foodstuffs. ABC transporters are there-
fore likely targets for drug therapy. A large number
of new studies focused on the ABC transporter
genes are anticipated.
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